Are you Dr. Santala?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
801 N 29th St
Billings, MT 59101Phone+1 406-238-2500
Summary
- Dr. Roger Santala, MD is an oncologist in Billings, Montana. He is currently licensed to practice medicine in Montana, North Dakota, and Wyoming. He is affiliated with Billings Clinic.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1971 - 1973- University of California (San Francisco)Internship, Internal Medicine, 1970 - 1971
Northwestern University The Feinberg School of MedicineClass of 1970
Certifications & Licensure
CA State Medical License 1972 - Present
MT State Medical License 1987 - 2026
WY State Medical License 1987 - 2025
ND State Medical License 1993 - 2021
SD State Medical License Active through 2019
CO State Medical License 1981 - 2017
IA State Medical License 1977 - 1981- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 76 citationsHigh-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysisJorge Nieva, Marco Wendel, Madelyn Luttgen, Dena Marrinucci, Lyudmila Bazhenova
Physical Biology. 2012-02-01 - 13 citationsIntergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for ...A. Bapsi Chakravarthy, Fengmin Zhao, Neal J. Meropol, Patrick J. Flynn, Lynne I. Wagner
The Oncologist. 2020-05-01 - 3 citationsPILOT STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL, ORAL LEUCOVORIN, AND UPPER-ABDOMINAL RADIATION THERAPY IN PATIENTS WITH LOCALLY ADVANCED RESIDUAL OR RECURRENT UPPER...James A. Martenson, Revathi Swaminathan, Patrick A. Burch, Roger G. Santala, Georgene Schroeder
International Journal of Radiation Oncology, Biology, Physics. 1997-02-01
Professional Memberships
- Member
